13.32
Schlusskurs vom Vortag:
$12.96
Offen:
$12.79
24-Stunden-Volumen:
171.97K
Relative Volume:
0.62
Marktkapitalisierung:
$693.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-41.43M
KGV:
-16.86
EPS:
-0.79
Netto-Cashflow:
$-39.97M
1W Leistung:
+1.76%
1M Leistung:
+11.56%
6M Leistung:
+46.53%
1J Leistung:
+83.72%
Gh Research Plc Stock (GHRS) Company Profile
Vergleichen Sie GHRS mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
GHRS
Gh Research Plc
|
13.32 | 780.95M | 0 | -41.43M | -39.97M | -0.79 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-06-04 | Fortgesetzt | Cantor Fitzgerald | Overweight |
2025-03-13 | Eingeleitet | Guggenheim | Buy |
2025-03-07 | Eingeleitet | RBC Capital Mkts | Outperform |
2025-02-13 | Eingeleitet | Cantor Fitzgerald | Overweight |
2022-08-16 | Eingeleitet | H.C. Wainwright | Buy |
2022-06-16 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Gh Research Plc Aktie (GHRS) Neueste Nachrichten
GH Research Unveils Promising GH001 Trial Data at ECNP 2025 - TipRanks
Real time alert setup for GH Research PLC performanceWeekly Gains Summary & Detailed Earnings Play Strategies - newser.com
What momentum shifts mean for GH Research PLCQuarterly Portfolio Summary & Fast Moving Stock Watchlists - newser.com
Is GH Research PLC stock a safe buy before earningsJuly 2025 Macro Moves & AI Enhanced Trading Signals - newser.com
Using fundamentals and technicals on GH Research PLC2025 Momentum Check & Verified High Yield Trade Plans - newser.com
Has GH Research PLC found a price floor2025 Volatility Report & Weekly High Conviction Trade Ideas - newser.com
Depression-Focused GH Research Shares Could See Significant Upside: Analyst - Benzinga
Is GH Research PLC stock a buy in volatile marketsQuarterly Market Review & Technical Confirmation Alerts - newser.com
Is GH Research PLC stock cheap at current valuationDay Trade & AI Driven Stock Price Forecasts - newser.com
Is GH Research PLC stock attractive for income investorsJuly 2025 Selloffs & Weekly Momentum Picks - newser.com
Combining machine learning predictions for GH Research PLCJuly 2025 Gainers & Free Reliable Trade Execution Plans - newser.com
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Needham Initiates Coverage of GH Research (GHRS) with Buy Recommendation - Nasdaq
How GH Research PLC stock responds to policy changesWeekly Stock Report & High Accuracy Swing Entry Alerts - newser.com
Signal strength of GH Research PLC stock in tech scannersMarket Risk Report & Verified Short-Term Plans - newser.com
GH Research Presents Promising GH001 Trial Data at ECNP 2025 - TipRanks
Can a trend reversal in GH Research PLC lead to recoveryRisk Management & Risk Managed Trade Strategies - newser.com
GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress - GlobeNewswire
GH Research PLC stock momentum explainedMarket Sentiment Report & Free Daily Entry Point Trade Alerts - newser.com
GH Research Showcases Promising Depression Treatment at ECNP 2025 - TipRanks
GH Research PLC Announces Acceptance of Presentation and Posters on GH001 for Treatment-Resistant Depression at ECNP Congress - Quiver Quantitative
No treatment-related SAEs: GH Research 6‑Month GH001 safety & psychoactive data for TRD at ECNP 2025 - Stock Titan
Will GH Research PLC stock outperform international peers2025 Historical Comparison & AI Powered Buy and Sell Recommendations - newser.com
GH Research's (GHRS) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Market reaction to GH Research PLC’s recent newsWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com
Can volume confirm reversal in GH Research PLCQuarterly Risk Review & High Win Rate Trade Alerts - newser.com
Does GH Research PLC qualify in momentum factor screeningMarket Activity Summary & Safe Investment Capital Preservation Plans - newser.com
Will GH Research PLC stock benefit from automationWall Street Watch & Low Drawdown Investment Ideas - newser.com
Why millennials buy GH Research PLC (1KA) stockJuly 2025 Fed Impact & AI Driven Price Forecasts - newser.com
Finanzdaten der Gh Research Plc-Aktie (GHRS)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):